Katherine Gorrell, with extensive healthcare experience, joins BioStem to lead legal and compliance functions for its growth and Nasdaq uplisting. LakeShore Biopharma to merge with Oceanpine Skyline Inc. in a going-private transaction valued at US$2.7 million.
